CARBASTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Carbastat, and when can generic versions of Carbastat launch?
Carbastat is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in CARBASTAT is carbachol. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the carbachol profile page.
Summary for CARBASTAT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Patent Applications: | 3,542 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CARBASTAT at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CARBASTAT
US Patents and Regulatory Information for CARBASTAT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | CARBASTAT | carbachol | SOLUTION;INTRAOCULAR | 073677-001 | Apr 28, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |